U.S. Spinal Non-Fusion Device Market 2018 Global Analysis by Major Players in Industry Includes Medtronic Spinal and Biologics, Raymedica, DePuy Synthes, Pioneer Surgical technologies

Optima Insights offers a latest report on “Spinal Non-Fusion Device Market” delivering key insights and providing a competitive advantage to clients through a detailed report. The report presents current market analysis, upcoming as well as future opportunities, revenue growth, pricing and profitability. The report contains basic, secondary and advanced information pertaining to the Spinal Non-Fusion Device Market status and trend, size, share, growth, trends, segment and forecasts

According to Optima Insights, the U.S. Spinal Non-Fusion Devices Market is estimated to be valued at US$ 305.51Mn in 2017 and is projected to exhibit a CAGR of 7.4% over the forecast period (2019 – 2023).

For Any Queries, Make an Enquiry Here @ https://www.optimainsights.org/categories/orthopedic-spine-trauma-devices

Key Trends and Analysis of the U.S.Spinal Non-Fusion Device Market:

The spinal non-fusion device market is estimated to grow with a healthy CAGR, which is expected to reach 416.48 Mn by 2023. Increased products lines with new technologies in artificial discs, annulus repair devices, motion sparing technologies, facet arthroplasty, posterior stabilization devices and nuclear disc prosthesis are driving the market to increase in a linear manner. The innovative technologies such as Vertical Expandable Prosthetic Titanium Rib (VEPTR) and pedicle screw tethering are helping the market with new solutions that are providing normal lifestyle to the patients with degenerative disc disease, spinal stenosis and degenerative spondylolisthesis etc. The disc nucleus replacement device market is expected to be the booming sector in the spinal non-fusion market segment.

Stringent regulatory guidelines for the market clearance, lack of scaled reimbursement policies and alternative methods for treatments are the major factors hindering the market growth.
More than 200,000 of population suffers with lumbar spinal stenosis and estimated to cross 65 million sufferers in next decade. Spinal stenosis costs over 50,000 to 90,000 USD.

According to the reports, between 2008 to 2014, it was observed that there was 33% increase in lumbar DDD and 42% increase in cervical DDD, which was 16.5% and 11% respectively between 2006 and 2012. The treatment for the DDD may range up to$20,000 to $150,000.US is the main market share holder as degenerative disc disease affects almost 50% of the population above age 40 years.
In U.S, about 28% of the people are over age 50 years, who are more prone to degenerative spondylolisthesis also there is an increase in the people suffering degenerative spondylolisthesisin U.S. which may boost the spinal non-fusion devices market.

The Spinal Non-Fusion Devices market is expected to increase significantly up to 416.5 million with increase in incidence of fractures due to increasing older population, technological advancements, increasing obese population, competitive spinal devices market and rising demand for minimally invasive procedures.

Key Market Takeaways:

• The U.S. Spinal Non-Fusion Device Market is expected to exhibit a CAGR of 7.4% during the forecast period (2019 – 2023), with the increase in U.S. orthopedic cases requiring artificial discs annulus repair devices posterior stabilization devices motion sparing technologies facet arthroplasty nuclear disc prosthesis for the treatment of degenerative disc disease, spinal stenosis and degenerative spondylolisthesis.

• Market growth has observed with the change in technology paving way for success of spinal non-fusion devices market. For instance, Vertical Expandable Prosthetic Titanium Rib (VEPTR) and pedicle screw tethering are the innovative technologies which are boosting the market growth

• A few key competitors operating in the U.S. Trauma Fixation Devices Market include Medtronic Spinal and Biologics, Raymedica, DePuy Synthes, Pioneer Surgical technologies, B. Braun Medical, Zimmer Spine, NuVasive, Globus Medical and Disc Motion Technologies.

• Few startups at a glance such as ZygoFix, Intelligent Implants, Minimally Invasive Spinal Technology, Viseon Spine, EDGe Surgical andHyalexOrthopaedics etc.

Optima Insights has a geographical/regional coverage on five major regions, include, North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. This extensive regional coverage also deep dives into major 26 countries, include, U.S., Canada, Brazil, Mexico, Argentina, Rest of Latin America, U.K., Germany, France, Italy, Spain, Russia and Rest of Europe, India, China, Japan, Australia, South Korea, Australia, ASEAN, Rest of Asia Pacific, Israel, GCC, Rest of Middle East, North Africa, Central Africa and South Africa.

For more details please log on to: www.optimainsights.org

About Optima Insights:

Optima Insights is an innovative research and insights driven enterprise committed to offer actionable intelligence to the global life science and healthcare market players. We believe that meaningful insights and improved strategic content holds the key to improved ROI for our clients. We strike an innovative engagement model with our clients to Co-Create Intelligence that would address very specific issues facing them within their functional areas to develop targeted research solutions at compelling price point. We continuously support clients through the entire journey map to enable them take better business decisions towards attaining market leadership.

Contact Details:
Chucks G
Director - Global Sales & BD
Optima Insights Pvt. Ltd.,
mail: sales@optimainsights.org
mob: +1 4242554365
www.optimainsights.org

This release was published on openPR.